Search research articles
Contact Us
Filters
Showing results (21-30 of 60) with videos related to
Page
of 6
Sort By:
Current Heart Failure Reports
|
November 8, 2013
Vasopressin receptor antagonists: from pivotal trials to current practice
Ankur Kalra, Valmiki Maharaj, Steven R Goldsmith
Progress in Cardiovascular Diseases
|
March 16, 2010
Congestion as a therapeutic target in acute heart failure syndromes
Steven R Goldsmith, Filippo Brandimarte, Mihai Gheorghiade
Expert Opinion on Pharmacotherapy
|
March 16, 2011
Tolvaptan for the treatment of heart failure: a review of the literature
Andrew Ambrosy, Steven R Goldsmith, Mihai Gheorghiade
Circulation. Heart Failure
|
May 22, 2014
Decongestive therapy and renal function in acute heart failure: time for a new approach?
Steven R Goldsmith, Bradley A Bart, John Burnett
The Journal of Thoracic and Cardiovascular Surgery
|
February 13, 2013
Appendicitis presenting as cardiac tamponade
Yader Sandoval, David M Williams, Steven R Goldsmith
Journal of Cardiac Failure
|
January 14, 2018
Dual Vasopressin V1a/V2 Antagonism: The Next Step in Neurohormonal Modulation in Patients With Heart Failure?
Steven R Goldsmith, James E Udelson, Mihai Gheorghiade
Journal of Cardiac Failure
|
May 8, 2010
The sympathorenal axis in hypertension and heart failure
Steven R Goldsmith, Paul A Sobotka, Bradley A Bart
Current Problems in Cardiology
|
January 10, 2018
Neurohormonal Imbalance: A Neglected Problem-And Potential Therapeutic Target-In Acute Heart Failure
Steven R Goldsmith, Bradley A Bart, Ileana L Pin A
Journal of Cardiac Failure
|
August 2, 2008
Ultrafiltration for cardiorenal syndrome
Bradley A Bart, Meghan M Walsh, Donnevan Blake, et al.
Journal of Cardiac Failure
|
August 2, 2008
Renal function and ultrafiltration
Bradley A Bart, Steven R Goldsmith, Andrew Boyle, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 60) with videos related to
Sort By:
Page
of 6
Current Heart Failure Reports
|
November 8, 2013
Vasopressin receptor antagonists: from pivotal trials to current practice
Ankur Kalra, Valmiki Maharaj, Steven R Goldsmith
Progress in Cardiovascular Diseases
|
March 16, 2010
Congestion as a therapeutic target in acute heart failure syndromes
Steven R Goldsmith, Filippo Brandimarte, Mihai Gheorghiade
Expert Opinion on Pharmacotherapy
|
March 16, 2011
Tolvaptan for the treatment of heart failure: a review of the literature
Andrew Ambrosy, Steven R Goldsmith, Mihai Gheorghiade
Circulation. Heart Failure
|
May 22, 2014
Decongestive therapy and renal function in acute heart failure: time for a new approach?
Steven R Goldsmith, Bradley A Bart, John Burnett
The Journal of Thoracic and Cardiovascular Surgery
|
February 13, 2013
Appendicitis presenting as cardiac tamponade
Yader Sandoval, David M Williams, Steven R Goldsmith
Journal of Cardiac Failure
|
January 14, 2018
Dual Vasopressin V1a/V2 Antagonism: The Next Step in Neurohormonal Modulation in Patients With Heart Failure?
Steven R Goldsmith, James E Udelson, Mihai Gheorghiade
Journal of Cardiac Failure
|
May 8, 2010
The sympathorenal axis in hypertension and heart failure
Steven R Goldsmith, Paul A Sobotka, Bradley A Bart
Current Problems in Cardiology
|
January 10, 2018
Neurohormonal Imbalance: A Neglected Problem-And Potential Therapeutic Target-In Acute Heart Failure
Steven R Goldsmith, Bradley A Bart, Ileana L Pin A
Journal of Cardiac Failure
|
August 2, 2008
Ultrafiltration for cardiorenal syndrome
Bradley A Bart, Meghan M Walsh, Donnevan Blake, et al.
Journal of Cardiac Failure
|
August 2, 2008
Renal function and ultrafiltration
Bradley A Bart, Steven R Goldsmith, Andrew Boyle, et al.
Page
of 6